InvestorsHub Logo
Followers 13
Posts 3218
Boards Moderated 0
Alias Born 04/26/2007

Re: None

Tuesday, 11/09/2021 12:24:24 PM

Tuesday, November 09, 2021 12:24:24 PM

Post# of 40501
11/9 The FDA has lifted the partial clinical hold following the FDA's review of additional non-clinical, clinical, and device information provided by INOVIO.
Dr. J. Joseph Kim, INOVIO's President and CEO, said, "I want to recognize and express my appreciation to my INOVIO colleagues for their hard work throughout this process. We are pleased to have the opportunity for U.S. clinical trial participants to potentially contribute to the enrollment in our INNOVATE Phase 3 segment. Today's U.S. announcement builds on our intensive global efforts in India ????, Brazil ????, Philippines ????, Mexico ????, Colombia ????, and Thailand ???? where we have received authorizations to date."[ China ????, Mali ???? from SVT, upcoming South Africa ????]

INOVIO is partnering with Advaccine Biopharmaceuticals Suzhou Co., Ltd. to conduct the INNOVATE Phase 3 segment in multiple countries in the Americas, Asia, and Africa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News